RVXoldtimer,

To all, please do not badger anyone for long past issues, although issues are still current.  C19 is here and causing too many problems, both with vaxed and non vaxed.  Non vaxed, hope you escape the virus.   Vaxed, yes, we have issues too, stay masked, work from home, no socializing, kids in school wear masks, and worldwide supply issues, just to name a few.  

To those in this this forum and many others, we know ABL is safe and has great ability to restore health within hours, days and weeks. Yet the powers to be, FDA, EDA and Health Canada will not recognize the value of ABL.  They must stay within the approved guide lines.  True, with one exception, why not all! 

C19 will be the savior of RVX and all its shareholders.  100 patients between two countries, will take only days to one week depending on how many patients agree to testing and those hospitals agree to the test protocol.  With an open test, word will first be on the internet, then local tv and national news.  Question, will FDA, EDA and Health Canada recognize the healing power of an oral drug from a no name small pharmaceutical in Canada.  Canada, you must be the advocate and first country to save your citizens even if the company is located in a political opposite area. You owe your citizens more and at the same time reduce to public funds on health care costs.  You can be a hero to all.

What might be next, need help here, believe test will start beginning of November or second week.  100 patients, two countries, first to second week full, four week test completed by mid December.  With open test, we should know by end of November.  Hard to keep a secret with open test. What will be Eversana's duties on this?

With positive results, what happens?  If there is an international announcement of results, SP will hit the roof.  How much, good guess here, slowly at first.  RVX should be asking for emergency release of ABL with continued study for P3.  At least we get paid for test.  It will take time.  Less time if Canada and Brazil opens full use of ABL.  FDA and EDA will be looking very close to results.  There will be pressure on those two.

Prediction, two to three weeks after published results share price will not jump as in widely held public companies.  Big jump will be when FDA and EDA gives approval.  Next big jump will be quarterly company results.

Yes this could be what many on this forum would call a block buster. sidebar